4.5 Article

Thyroid function analysis after roxadustat or erythropoietin treatment in patients with renal anemia: a cohort study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

Treatment of Renal Anemia in Patients With Hemodialysis Using Hypoxia-inducible Factor (HIF) Stabilizer, Roxadustat: A Short-term Clinical Study

Akira Mima et al.

Summary: This study evaluated the efficacy of Roxadustat in treating renal anemia in patients undergoing hemodialysis. The results showed that Roxadustat effectively increased and maintained hemoglobin levels. Although there was a tendency for ferritin and C-reactive protein levels to decrease, the difference was not statistically significant. Additionally, no significant adverse effects were observed during the study.

IN VIVO (2022)

Article Pharmacology & Pharmacy

Hypoxia-inducible factor-prolyl hydroxylase inhibitors for renal anemia in chronic kidney disease: Advantages and disadvantages

Akira Mima

Summary: Anemia is a common feature and complication of chronic kidney disease (CKD), with treatments such as ESAs and HIF-PHIs being widely used. HIF-PHIs show promise in improving renal anemia treatment by lowering hepcidin levels, modulating iron metabolism, reducing inflammation, and oxidative stress. However, further studies are needed to evaluate the long-term effects and potential risks of HIF-PHIs in clinical practice.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Article Urology & Nephrology

Roxadustat and thyroid-stimulating hormone suppression

Atsuyuki Tokuyama et al.

Summary: This study found that in CKD patients, switching from darbepoetin alfa to roxadustat may lead to abnormal levels of thyroid-stimulating hormone in hemodialysis patients, which can be reversed after stopping the medication.

CLINICAL KIDNEY JOURNAL (2021)

Article Urology & Nephrology

Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis

Mitsuru Ichii et al.

Summary: Physicians should be aware of the potential impact of roxadustat on thyroid hormone homeostasis, as demonstrated by the case of a patient with primary hypothyroidism who experienced reversible suppression of TSH secretion and decreased FT4 levels after starting roxadustat therapy. It is important to monitor thyroid hormone levels in patients receiving roxadustat treatment to ensure timely detection and management of any abnormalities.

BMC NEPHROLOGY (2021)

Review Urology & Nephrology

The Interplay Between Thyroid Dysfunction and Kidney Disease

Yoko Narasaki et al.

Summary: Hypothyroidism is common in CKD patients and has a bidirectional relationship with kidney disease, but there are gaps in knowledge regarding clinical management. Future research is needed to establish appropriate screening, diagnosis, and treatment approaches.

SEMINARS IN NEPHROLOGY (2021)

Article Urology & Nephrology

Prevalence of Hypothyroidism among Dialysis Patients in Palestine: A Cross-Sectional Study

Zaher A. Nazzal et al.

INTERNATIONAL JOURNAL OF NEPHROLOGY (2020)

Article Medicine, General & Internal

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis

N. Chen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis

N. Chen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Editorial Material Urology & Nephrology

A new approach to treating renal anaemia

Patrick H. Maxwell

NATURE REVIEWS NEPHROLOGY (2019)

Review Hematology

Anemia of inflammation

Guenter Weiss et al.

Article Urology & Nephrology

Prevalence of Subclinical Hypothyroidism in Patients with Chronic Kidney Disease on Maintenance Hemodialysis

Fahad Naseem et al.

SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION (2018)

Article Urology & Nephrology

Prevalence of hypothyroidism and thyroid nodule in chronic hemodialysis Iranian patients

Maryam Pakfetrat et al.

HEMODIALYSIS INTERNATIONAL (2017)

Article Urology & Nephrology

Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease

Ashraf Mikhail et al.

BMC NEPHROLOGY (2017)

Article Urology & Nephrology

Thyroid Status, Quality of Life, and Mental Health in Patients on Hemodialysis

Connie M. Rhee et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Review Urology & Nephrology

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD

Nupur Gupta et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2017)

Review Urology & Nephrology

Thyroid Function Test Derangements and Mortality in Dialysis Patients: A Systematic Review and Meta-analysis

Hong Xu et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2016)

Review Endocrinology & Metabolism

The interaction between thyroid and kidney disease: an overview of the evidence

Connie M. Rhee

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2016)

Article Endocrinology & Metabolism

Association of Thyroid Functional Disease With Mortality in a National Cohort of Incident Hemodialysis Patients

Connie M. Rhee et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Article Medicine, General & Internal

Prevalence of chronic kidney disease in China: a cross-sectional survey

Luxia Zhang et al.

LANCET (2012)